SCR-LIP-000628 · Claim · machine-readable JSON →
Diabetes is reported less frequently in lipedema and lipedema-like peripheral fat distribution than in comparison groups, although adiposity matching is limited.
General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 4 source(s) · by Amato
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (4)
- Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity — Amato et al. (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
In a population-based NHANES analysis, the DXA-defined lipedema phenotype was associated with lower diabetes prevalence (1.8% vs 8.1%; OR 0.21; 95%CI 0.08-0.51; p<0.001).
Exploratory cross-sectional population study directly examines whether a peripheral/gynoid (lipedema-like) fat distribution confers metabolic protection, reporting lower HOMA-IR and reduced diabetes prevalence with dose-response; supports t - Lipedema: friend and foe — Torre et al. (2018) ✓ verified — consistent · case series · 2018 · reading confidence: moderate
“Perfil cardiometabólico PROTETOR apesar de IMC obeso médio 35,3±1,7 kg/m²: diabetes apenas 2% (vs. ~10% mulheres NHANES idade-pareada); dislipidemia 11,7% (vs. 33,5%); hipertensão 13% (vs. 32,4% mulheres 40-59 anos)”
Chart review of 46 women with lipedema (mean BMI 35.3): diabetes 2% (vs ~10% in age-matched NHANES women), dyslipidemia 11.7% (vs 33.5%), hypertension 13% (vs 32.4%).
The article describes lipedema as a distinct disorder frequently misdiagnosed as obesity or lymphedema, with characteristic fat distribution, staging, inheritance pattern, and a metabolic profile differing from obesity; supports the affirma - Lipedema: A Disease Triggered by M2 Polarized Macrophages? (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“Diabetes tipo 2: incidência MENOR em pacientes com lipedema vs. controles femininos BMI-matched — efeito 'protetor' da deposição adiposa subcutânea gluteofemoral”
Review reports lower type 2 diabetes incidence in lipedema than in BMI-matched female controls, plus preserved insulin sensitivity and normal CRP, attributed to protective gluteofemoral fat.
The review explicitly reports lower type 2 diabetes incidence and a favorable metabolic profile in lipedema despite high BMI, describing the gluteofemoral fat deposition as 'protective' — directly affirmative to the question regarding metab - Peripheral fat distribution, the lipedema-associated phenotype, and lower prevalence of cardiometabolic disease in women: a cross-sectional study (NHANES 2011-2018) — Amato ACM, Amato JLS, Benitti DA (2026) ✓ verified — consistent · cross sectional · n=4986 · 2026 · risk of bias: moderate · reading confidence: high
“Diabetes 465 0.17 (0.12-0.25) <0.001”
In 4,986 NHANES women, the DXA peripheral fat phenotype was associated with lower diabetes prevalence (1.8% vs 13.6%; OR 0.17, 95%CI 0.12-0.25, adjusted for body-fat category, age, race/ethnicity and smoking; diabetes = self-report or HbA1c ≥6.5%); cross-sectional.
Overlaps the NHANES 2011-2014 participants of DOI:10.7759/cureus.104222 (same group, similar phenotype): not an independent sample for diabetes.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000010
- 2026-11-20 — evidence added · finding from DOI:10.1590/1677-5449.202600752 (supporting)